Back

Renal denervation improves metabolic parameters and reduces SCORE2-estimated cardiovascular risk in uncontrolled hypertension

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Renal denervation in hypertension Device Treatment and Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Venera Bytyqi

University Hospital Erlangen, Erlangen (Germany)

6 More presentations in this session

Presentation thumbnail
Long-term effects of renal denervation on hypertension management: insights from a center of excellence
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Blood pressure lowering effects of pharmacological and device-based interventions for resistant hypertension: a systematic review and meta-analysis
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Renal denervation in contemporary clinical practice: patient profile and early outcomes
Doctor I. Nobrega Fernandes (Vila Real, PT)
Abstract Slides Video
Presentation thumbnail
Durable 13-year outcomes after renal denervation in patients with resistant arterial hypertension in Ukraine
Doctor O. Rekovets (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
Long-term effects of renal denervation on hypertension management: a systematic review and meta-analysis
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Renal denervation in hypertension

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Can renal denervation reduce cardiovasculer events?
27 August 2022
thumbnail
Congress Presentation
Integrated multi-omics analysis reveals the molecular mechanisms of renal denervation in alleviating diabetic cardiomyopathy
29 August 2026
thumbnail
Congress Presentation
10 years after treatment with renal denervation of the sympathetic nerves for resistant hypertension: what happened to the patients and their office blood pressure? An observational study
1 September 2024
thumbnail
Congress Presentation
Efficacy and safety aspects of renal denervation in treatment of arterial hypertension: a systematic review and meta-analysis
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources